Safe Administration of Haloperidol, Promethazine, and Lorazepam

Physical Compatibility Evidence

The American Academy of Pediatrics explicitly states that combinations of a butyrophenone (haloperidol) and a benzodiazepine (lorazepam) may be administered in the same syringe 1
There is no published evidence supporting the physical or chemical compatibility of all three medications (haloperidol, promethazine, and lorazepam) in a single syringe 1, 2

The American Academy of Pediatrics recommends a first injection of haloperidol 5 mg + lorazepam 2 mg mixed in the same syringe, and a second injection of promethazine 25-50 mg given separately 1, 3
This approach provides the additive calming effects of haloperidol-lorazepam while adding promethazine's antihistamine properties to reduce extrapyramidal symptoms 1

The American Academy of Pediatrics states that combining lorazepam with haloperidol requires close cardiorespiratory monitoring with pulse oximetry 1
All three medications can prolong the QTc interval, with additive effects when combined, and baseline ECG should be obtained if feasible 1
Haloperidol causes 7 ms mean QTc prolongation, and risk increases with combination therapy 4

The American Academy of Pediatrics recommends assessing cardiac risk factors and obtaining ECG if time permits before administering haloperidol, promethazine, and lorazepam 1, 4
Reduce doses by 50% in elderly patients (haloperidol 0.25-0.5 mg, lorazepam 1 mg) 3
Monitor continuously for respiratory depression, excessive sedation, and cardiac arrhythmias for a minimum of 8 hours 1

The American Academy of Pediatrics warns against assuming all three drugs are compatible in one syringe, as there is no evidence supporting this 1, 2
Avoid using haloperidol alone without either promethazine or having diphenhydramine immediately available, as dystonia rates are unacceptably high 4, 3
Avoid this combination in patients with Parkinson's disease or Lewy body dementia, as haloperidol will cause severe extrapyramidal symptoms regardless of promethazine 4, 3

The American Academy of Pediatrics confirms that combinations of a butyrophenone (haloperidol) and a benzodiazepine (lorazepam) may be administered together in one syringe 5

The American Academy of Pediatrics mandates close cardiorespiratory monitoring with pulse oximetry when combining lorazepam with haloperidol 5
Benzodiazepines carry risk of respiratory depression, with midazolam having higher risk than lorazepam (one case of respiratory depression occurred in 0.7% receiving midazolam versus 1% receiving lorazepam) 6

Reduce doses by 50% in elderly patients: haloperidol 0.25-0.5 mg, lorazepam 1 mg 7
Pediatric dosing (ages 6-12): haloperidol 2.5 mg, lorazepam 0.05-0.1 mg/kg 5

Avoid this combination in patients with Parkinson's disease or Lewy body dementia – haloperidol will cause severe extrapyramidal symptoms regardless of promethazine co-administration 7
Do not use in patients with delirium – promethazine's anticholinergic properties may worsen confusion 7

The combination of haloperidol with promethazine showed superior efficacy compared to haloperidol alone, with significantly fewer people requiring additional medication (NNT 7) and dramatically reduced dystonia risk 6
When haloperidol-promethazine was compared to lorazepam alone, the combination produced more rapid tranquilization with more patients tranquil or asleep at 30 minutes (NNT 8) 6